Skip to main content
. 2019 Sep 6;11(9):1316. doi: 10.3390/cancers11091316

Figure 1.

Figure 1

Final sensitivity of TGCTs cell lines to CDDP measured by MTS assays after 72 h of CDDP treatment: (a) CDDP-naive (NCCIT) and CDDP-treated (NCCIT_CDDP) NCCIT cell lines; (b) CDDP-naive (Tera-2) and CDDP-treated (Tera-2_CDDP) Tera-2 cell lines (the means and SDs of 4 independent assays for each cell line are displayed, each assay analyzed in triplicates or 6-plicates).